Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-09-13Clinical Trial Update: Domperidone for Relief of Gastrointestinal Disorders [NA]
The clinical trial evaluating domperidone for relief of various gastrointestinal disorders has been terminated.
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy [NA]
A clinical trial evaluating reflux disease in head and neck cancer patients undergoing radiation therapy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-11Clinical Trial Update: Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain [Phase 4]
Phase 4 trial of Dexilant (dexlansoprazole) for gastroesophageal reflux disease-related non-cardiac chest pain was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-20Clinical Trial Update: Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux [Phase 3]
This Phase 3 pediatric study on chronic cough and gastroesophageal reflux has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-19Clinical Trial Update: Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating predictors of proton pump inhibitor response in eosinophilic esophagitis and gastroesophageal re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-01-18Clinical Trial Update: Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD [Phase 3]
A Phase 3 trial evaluating double-dose rabeprazole for symptom control in non-erosive gastroesophageal reflux disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2009-08-03Clinical Trial Update: vMII for Measurement of Oesophageal Bolus Transport and Reflux [NA]
The clinical trial NCT00604942 evaluating vMII for measuring oesophageal bolus transport and reflux was terminated.
-
CLINICAL_TRIALS withdrawal · 2009-06-08Clinical Trial Update: The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease [Phase 3]
A Phase 3 clinical trial evaluating melatonin for gastroesophageal reflux disease has been withdrawn.